Figure 1. Real-time RT-PCR of DYRK1A mRNA level of in 55 newly diagnosed adult AML patients, 16 relapsed/refractory adult AML patients and 24 normal controls.

GAPDH was used as internal control. Solid points indicate individual values and horizontal lines represent medians. The differences in copy number of each gene in the newly diagnosed, relapsed/refractory patients and normal controls were performed using a one-way ANOVA test.